Send to

Choose Destination
See comment in PubMed Commons below
Med Clin North Am. 2013 Jan;97(1):115-34. doi: 10.1016/j.mcna.2012.10.004. Epub 2012 Dec 7.

Potential new treatments for diabetic kidney disease.

Author information

  • 1Purdue University College of Pharmacy, West Lafayette, IN 47907-2091, USA.


Antifibrotic agents, antioxidant agents, ET-a receptor antagonists, and a few other agents with nonspecific or multifaceted mechanisms of action have been evaluated and progressed to small clinical studies in human subjects. Although there are limited data at the present time, these early evaluations have produced some favorable results that at least warrant further investigation. There is certainly not enough compelling evidence to justify the routine use of any of these products specifically for DKD at the moment; however, more well-controlled and adequately powered studies in several hundred patients will help determine which of these may have a place in the DKD treatment armamentarium of the future.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center